35 results
10-K
2024 FY
IXHL
Incannex Healthcare Limited
30 Sep 24
Annual report
7:30am
, coverage and reimbursement of our drug candidates, if approved and commercialized;
the rate and degree of market acceptance and clinical utility … dietary supplement, future enacted legislation or federal government action authorizing the sale, distribution, use, and insurance reimbursement of non
10-K
2024 FY
EX-97.1
IXHL
Incannex Healthcare Limited
30 Sep 24
Annual report
7:30am
to the Company’s material noncompliance with any financial reporting requirement, the Compensation Committee will require reimbursement or forfeiture of any excess … , the method for recouping Incentive Compensation. Such method may include:
requiring reimbursement of cash Incentive Compensation previously paid;
seeking
8-K
EX-10.2
IXHL
Incannex Healthcare Limited
10 Sep 24
Entry into a Material Definitive Agreement
7:30am
or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including … such reimbursement obligation of the Company then due. The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same
S-1/A
EX-10.10
IXHL
Incannex Healthcare Limited
17 Jul 24
IPO registration (amended)
8:47am
, or in the case of mutilated certificates, the surrender of the certificate or portion thereof remaining) and (ii) reimbursement to the Company
S-1/A
IXHL
Incannex Healthcare Limited
17 Jul 24
IPO registration (amended)
8:47am
our drug candidates; and
we may not be able to obtain and maintain coverage and adequate reimbursement from third party payors.
If any … clinicians and physicians for our drug candidates;
cost-effectiveness compared to existing and new treatments;
availability of coverage, reimbursement
S-1
tgs12w4ym
3 Jul 24
IPO registration
6:29am
10-Q
ivk55
14 Feb 24
Quarterly report
6:16am
S-8
zndgkub
20 Dec 23
Registration of securities for employees
5:05pm
8-K
EX-10.1
seu73m
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm
8-K
EX-3.2
fadg1 0ayxaf
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm
20-F
g8lrmeicyybs1dm4quos
28 Oct 22
Annual report (foreign)
6:31am
20-F
EX-4.11
u3j40gzm7u2
28 Oct 22
Annual report (foreign)
6:31am
20FR12B/A
pwr68lkob5snqua
24 Feb 22
Initial registration of securities (foreign private issuers) (amended)
3:42pm
20FR12B/A
iszqy
22 Feb 22
Initial registration of securities (foreign private issuers) (amended)
6:10am
F-6/A
EX-99
umwuwmmvg7gyn4f c0f
17 Feb 22
Registration for ADRs (foreign) (amended)
1:07pm
20FR12B
EX-4.6
38c6x sthgp1wef
24 Jan 22
Initial registration of securities (foreign private issuers)
8:18pm
20FR12B
c892cnc
24 Jan 22
Initial registration of securities (foreign private issuers)
8:18pm
20FR12B
EX-2.1
851wcu
24 Jan 22
Initial registration of securities (foreign private issuers)
8:18pm